Literature DB >> 30009888

Metabolomic analysis of cholestatic liver damage in mice.

Rui Yang1, Qi Zhao1, Dan-Dan Hu2, Xue-Rong Xiao3, Jian-Feng Huang1, Fei Li4.   

Abstract

Cholestasis is characterized by the obstruction of bile duct, including primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). The complicated etiology and injury mechanism greatly limits the development of new drugs for its treatment. To better understand the mechanism of cholestatic liver damage, ultra-performance liquid chromatography-linked electrospray ionization quadrupole time-of-flight mass spectrometry (UPLC-ESI-QTOFMS) and multivariate data analysis were used to determine the metabolic changes in three recognized mouse cholestasis models. The cholestatic liver damage was generated by alphanaphthyl isothiocyanate (ANIT), 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) and lithocholic acid (LCA). The results indicated that the levels of bile acids were commonly increased in plasma of three mouse cholestasis models, while arginine was decreased. The level of plasma glutathione was decreased in ANIT- and LCA-induced intrahepatic PBC and PSC, respectively. But, the liver glutathione was decreased in DDC induced extrahepatic PSC. The level of plasma phospholipids was elevated in ANIT and DDC models, whereas that was depleted in LCA model. And protoporphyrin IX was significantly increased in the liver of DDC model. These metabolomics data could potentially distinguish the metabolic differences of three types of cholestasis, contributing to the understanding of the potential mechanism of cholestatic liver damage.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cholestatic liver damage; Metabolomics; PBC; PSC; QTOFMS

Mesh:

Substances:

Year:  2018        PMID: 30009888     DOI: 10.1016/j.fct.2018.07.022

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  5 in total

Review 1.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Metabolites       Date:  2020-01-28

2.  Industrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis.

Authors:  Vânia Vilas-Boas; Eva Gijbels; Axelle Cooreman; Raf Van Campenhout; Emma Gustafson; Kaat Leroy; Mathieu Vinken
Journal:  Chem Res Toxicol       Date:  2019-06-18       Impact factor: 3.739

3.  Integrated Lipidomics and Metabolomics Study of Four Chemically Induced Mouse Models of Acute Intrahepatic Cholestasis.

Authors:  Weiwei Li; Hui Chen; Yihan Qian; Shouchuan Wang; Zichen Luo; Jinjun Shan; Xiaoni Kong; Yueqiu Gao
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

Review 4.  Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology.

Authors:  Ming-Ling Chang; Sien-Sing Yang
Journal:  Cells       Date:  2019-11-12       Impact factor: 6.600

5.  Targeted bile acid profiles reveal the liver injury amelioration of Da-Chai-Hu decoction against ANIT- and BDL-induced cholestasis.

Authors:  YueHua Zhou; YunZhong Zhou; YiFei Li; Wei Sun; ZhaoLong Wang; Long Chen; Ye He; XiaoLong Niu; Jialiang Chen; Guangtao Yao
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.